The experimental drug Bremelanotide (formerly PT-141) does not act on the vascular system like the former compounds but increases sexual desire and drive in male as well as female. It is applied as a nasal spray. Bremelanotide works by activating melanocortin receptors in the brain. It is currently in Phase IIb trials. super sales of viagra online Buy viagra online canada buy viagra c.o.d viagra pills sale online order order phentermine viagra viagra online canadian pharmacy buy viagra online viagra buy to viagra where viagra for sale viagra in canada viagra pills for sale viagra sample pack check buy viagra canadian pharmacy free viagra order online viagra online canadian pharmacy online viagra viagra The study authors focused on 12 patients who had been diagnosed with chronic obstructive pulmonary disease and were suspected of having PAH. Throughout the study, right heart blood pressure was tracked among all 12 patients by inserting a thin plastic tube into the pulmonary artery -- a procedure known as cardiac catheterization. Cardiac blood pressure was measured at rest and just after all the patients cycled for three minutes. discounted viagra for sale viagra online buy viagra viagra online viagra genericviagra online Yohimbine improves erections for a small percentage of men. It stimulates the parasympathetic nervous system, which is linked to erection, and may increase libido. It is necessary to take the medication for 6 to 8 weeks before determining whether it will work or not. Second, an undescended testicle is more likely to develop a tumor. Testicular cancer affects one of every 2,000 men with undescended testicles. This rate of testicular cancer is higher than the rate in men whose testicles have dropped naturally. When the testicle is inside the scrotum, a man can easily feel his testicles to check for a tumor, or he can be checked by his doctor. This way, any tumor can be found early, when the cancer is easier to cure. Forget Viagra! Sound waves can send your sex life into orbit best price viagra viagra
 
 
Show background image
Thursday, 31 July 2014

Cool Pictures

Shirini Yazdi

Home  >  Media  >  News Release

Experts warn that e-cigarettes can damage the lungs

E-cigaretteVienna, Austria: New research has shown that despite electronic cigarettes being marketed as a potentially safer alternative to normal cigarettes, they are still causing harm to the lungs.

 

A new study, presented today (Sunday 2 September 2012) at the European Respiratory Society’s Annual Congress in Vienna, has added new evidence to the debate over the safety of alternative nicotine-delivery products.

 

Electronic cigarettes are devices that deliver nicotine through a vapour, rather than smoke. There is no combustion involved but the nicotine in the device is still derived from tobacco. There has been much debate over the safety and efficiency of the products, but little scientific evidence to support either claim.

 

Researchers from the University of Athens in Greece aimed to investigate the short-term effects of using e-cigarettes on different people, including people without any known health problems and smokers with and without existing lung conditions.

 

The study included 8 people who had never smoked and 24 smokers, 11 with normal lung function and 13 people with either chronic obstructive pulmonary disease (COPD) or asthma.

Each person used an electronic cigarette for 10 minutes. The researchers then measured their airway resistance using a number of tests, including a spirometry test.

 

The results showed that for all people included in the study, the e-cigarette caused an immediate increase in airway resistance, lasting for 10 minutes. In healthy subjects (never smokers) there was a statistically significant increase in airway resistance from a mean average of 182% to 206%.

 

In smokers with normal spirometry there was a statistically significant increase from a mean average of 176% to 220%. In COPD and asthma patients the use of one e-cigarette seemed to have no immediate effect to airway resistance.

 

Professor Christina Gratziou, one of the authors and Chair of the ERS Tobacco Control Committee, said: “We do not yet know whether unapproved nicotine delivery products, such as e-cigarettes, are safer than normal cigarettes, despite marketing claims that they are less harmful. This research helps us to understand how these products could be potentially harmful.

 

“We found an immediate rise in airway resistance in our group of participants, which suggests e-cigarettes can cause immediate harm after smoking the device. More research is needed to understand whether this harm also has lasting effects in the long-term.

 

“The ERS recommends following effective smoking cessation treatment guidelines based on clinical evidence which do not advocate the use of such products.”

Notes to editors:

  • Abstract: LATE-BREAKING ABSTRACT: Acute effect of e-cigarette on pulmonary function in healthy subjects and smokers
  • Session: 109
  • Date and time: Sunday 2 September, 12:50-14:40
  • Room: Halle A-29

Press Office at ERS Congress in Vienna (Saturday 1st August - Wednesday 5th September 2012):

Lauren Anderson: +43 6763315356  This e-mail address is being protected from spambots. You need JavaScript enabled to view it

David Sadler: +43 6767502294

Abstract Print Zone

Browse the electronic book online, print the selected pages or download the full abstract book.

Access it now